Abstract:Mass spectrometric imaging is a nontargeted, tag-free, high-throughput, and highly responsive analytical approach. The highly accurate molecular visualization detection technology enables qualitative and quantitative analyses of biologic tissues or cells scanned by mass spectrometry in situ, extracting known and unknown multiple compounds, and simultaneously assessing relative contents of targeting molecules by monitoring their molecular ions and pinpointing the spatial locations of those molecules distributed. Five mass spectrometric imaging techniques and their characteristics are introduced in the review, including matrix-assisted laser desorption ionization mass spectrometry, secondary ion mass spectrometry, desorption electrospray ionization mass spectrometry, laser ablation electrospray ionization mass spectrometry, and laser ablation inductively coupled plasma mass spectrometry. The mass spectrometry-based techniques provide the possibility for spatial metabolomics with the capability of high throughput and precision detection. The approaches have been widely employed to spatially image not only metabolome of endogenous amino acids, peptides, proteins, neurotransmitters, and lipids but also the disposition of exogenous chemicals, such as pharmaceutical agents, environmental pollutants, toxicants, natural products, and heavy metals. The techniques also provide us with spatial distribution imaging of analytes in single cells, tissue microregions, organs, and whole animals. SIGNIFICANCE STATEMENT: The review article includes an overview of five commonly used mass spectrometers for spatial imaging and describes the advantages and disadvantages of each. Examples of the technology applications cover drug disposition, diseases, and omics. Technical aspects of relative and absolute quantification by mass spectrometric imaging and challenges for future new applications are discussed as well. The reviewed knowledge may benefit the development of new drugs and provide a better understanding of biochemical processes related to physiology and diseases.

A new direction in metabolomics: Analysis of the central nervous system based on spatially resolved metabolomics

Dissecting the Brain with Spatially Resolved Multi-Omics

New perspective on central nervous system disorders: focus on mass spectrometry imaging

Mapping Metabolic Networks in the Brain by Ambient Mass Spectrometry Imaging and Metabolomics

Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets

Spatially resolved metabolomics: From metabolite mapping to function visualising

A Review of the Application of Spatial Transcriptomics in Neuroscience

Application of spatial transcriptome technologies to neurological diseases

High spatial resolution mass spectrometry imaging for spatial metabolomics: Advances, challenges, and future perspectives

Mass spectrometry for biomarkers, disease mechanisms, and drug development in cerebrospinal fluid metabolomics

Multiscale metabolomics techniques: Insights into neuroscience research

Advancements in Single-Cell RNA Sequencing and Spatial Transcriptomics for Central Nervous System Disease

Spatial metabolomics in head and neck tumors: a review

Frontiers in Mass Spectrometry-Based Spatial Metabolomics: Current Applications and Challenges in the Context of Biomedical Research

Editorial: Spatiotemporal regulation of central nervous system disorders: molecular mechanisms and emerging techniques

Progress of metabolomics in the neuropsychiatric diseases

Recent Advances in Mass Spectrometry-Based Spatially Resolved Molecular Imaging of Drug Disposition and Metabolomics

Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human injured brain

Spatial neurolipidomics—MALDI mass spectrometry imaging of lipids in brain pathologies

Spatial Multiomics Analysis in Psychiatric Disorders.

Progress Of Mass Spectrometry Imaging In Neuroscience